Literature DB >> 16232041

Virtual reality cue reactivity assessment in cigarette smokers.

Patrick S Bordnick1, Ken M Graap, Hilary L Copp, Jeremy Brooks, Mirtha Ferrer.   

Abstract

Drug craving has purportedly been linked to relapse and to substance use. For over two decades, cue reactivity has been a viable method to assess craving and physiological reactions to drug stimuli. However, traditional cue reactivity has faced the following limitations: austere situations or stimuli, lack of complex cues, lack of standardization, and limited generalization outside of the lab setting. In order to improve cue methodologies, a virtual reality (VR) nicotine cue reactivity assessment system (VR-NCRAS) was developed and tested in a controlled experimental trial. Ten nicotine dependent smokers were exposed to VR smoking cues and VR neutral cues in a standardized, timed, computer controlled experiment. Subjective craving and physiological responses were recorded and compared across VR-NCRAS stimuli. Subjective cigarette craving increased significantly and corresponding physiological reactivity was observed in response to VR smoking cues. VR neutral cues did not result in subjective or physiological changes consistent with craving. Implications of these findings on substance abuse research and treatment are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16232041     DOI: 10.1089/cpb.2005.8.487

Source DB:  PubMed          Journal:  Cyberpsychol Behav        ISSN: 1094-9313


  27 in total

Review 1.  Counterbalancing in smoking cue research: a critical analysis.

Authors:  Michael A Sayette; Kasey M Griffin; W Michael Sayers
Journal:  Nicotine Tob Res       Date:  2010-09-30       Impact factor: 4.244

2.  Methamphetamine craving induced in an online virtual reality environment.

Authors:  Christopher Culbertson; Sam Nicolas; Itay Zaharovits; Edythe D London; Richard De La Garza; Arthur L Brody; Thomas F Newton
Journal:  Pharmacol Biochem Behav       Date:  2010-07-17       Impact factor: 3.533

3.  Location and longing: the nicotine craving experience in virtual reality.

Authors:  Brian L Carter; Patrick Bordnick; Amy Traylor; Susan X Day; Megan Paris
Journal:  Drug Alcohol Depend       Date:  2008-02-19       Impact factor: 4.492

4.  The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions.

Authors:  Yahui Kang; Joseph N Cappella; Andrew A Strasser; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2009-02-27       Impact factor: 4.244

5.  Turning virtual reality into reality: a checklist to ensure virtual reality studies of eating behavior and physical activity parallel the real world.

Authors:  Aner Tal; Brian Wansink
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

6.  Behavioral economic analysis of cue-elicited craving for tobacco: a virtual reality study.

Authors:  John Acker; James MacKillop
Journal:  Nicotine Tob Res       Date:  2013-01-15       Impact factor: 4.244

7.  Influence of point-of-sale tobacco displays and graphic health warning signs on adults: evidence from a virtual store experimental study.

Authors:  Annice E Kim; James M Nonnemaker; Brett R Loomis; Paul R Shafer; Asma Shaikh; Edward Hill; John W Holloway; Matthew C Farrelly
Journal:  Am J Public Health       Date:  2014-03-13       Impact factor: 9.308

8.  VIRTUAL REALITY CUE EXPOSURE THERAPY FOR THE TREATMENT OF TOBACCO DEPENDENCE.

Authors:  Christopher S Culbertson; Stephanie Shulenberger; Richard De La Garza; Thomas F Newton; Arthur L Brody
Journal:  J Cyber Ther Rehabil       Date:  2012

9.  Cue reactivity in virtual reality: the role of context.

Authors:  Megan M Paris; Brian L Carter; Amy C Traylor; Patrick S Bordnick; Susan X Day; Mary W Armsworth; Paul M Cinciripini
Journal:  Addict Behav       Date:  2011-01-26       Impact factor: 3.913

10.  A Feasibility Study of Virtual Reality-Based Coping Skills Training for Nicotine Dependence.

Authors:  Patrick S Bordnick; Amy C Traylor; Brian L Carter; Ken M Graap
Journal:  Res Soc Work Pract       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.